Filed Pursuant to Rule 424(b)(3)
Registration No. 333-260714
PROXY STATEMENT/PROSPECTUS SUPPLEMENT NO. 1
(To the Proxy Statement/Prospectus dated December 23, 2021)
PROXY STATEMENT FOR
EXTRAORDINARY GENERAL MEETING OF TREBIA ACQUISITION CORP.
(“TREBIA”) AND
PROSPECTUS FOR
64,530,520 SHARES OF CLASS A COMMON STOCK, PAR VALUE $0.0001 PER
SHARE, AND
17,250,000 WARRANTS TO PURCHASE CLASS A COMMON
STOCK OF
TREBIA ACQUISITION CORP. (AFTER ITS DOMESTICATION AS A DELAWARE CORPORATION, WHICH WILL BE RENAMED SYSTEM1, INC. IN CONNECTION WITH
THE BUSINESS COMBINATION DESCRIBED HEREIN)
This proxy statement/prospectus supplement (the “Supplement”) supplements the proxy statement/prospectus, dated December 23, 2021 (the “Proxy Statement/Prospectus”), which forms a part of our Registration Statement on Form S-4 (No. 333-260714). The Proxy Statement/Prospectus and this Supplement relate to the issuance by us, in connection with the Business Combination and following the Domestication, in each case as discussed in the Proxy Statement/Prospectus, of an aggregate of 64,530,520 shares of Class A common stock, $0.0001 par value per share, of System1 (as defined in the Proxy Statement/Prospectus) and up to 17,250,000 shares of Class A common stock of System1 that are issuable upon the exercise of 17,250,000 warrants (the “Public Warrants”) originally issued in Trebia’s initial public offering.
Trebia’s units, Class A ordinary shares and warrants are currently listed on the New York Stock Exchange (the “NYSE”) under the symbols TREB.U, TREB and TREB.WS, respectively. Trebia intends to apply for listing on the NYSE, effective upon the completion of the Business Combination, of System1’s Class A common stock and warrants under the proposed symbols “SST” and “SST.WS” respectively. Trebia is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and has elected to comply with certain reduced public company reporting requirements.
This Supplement should be read together with the Proxy Statement/Prospectus, including any further amendments or supplements thereto, which is to be delivered with this Supplement. This Supplement is qualified by reference to the Proxy Statement/Prospectus, including any amendments or supplements thereto, except to the extent that the information in this proxy statement/prospectus supplement updates and supersedes the information contained therein. On January 7, 2022, the closing price of our Class A ordinary shares was $9.96 per share and the closing price for our Public Warrants was $1.19.
This Supplement is not complete without, and may not be delivered or utilized except in connection with, the Proxy Statement/Prospectus, including any amendments or supplements thereto.
We are an “emerging growth company” as defined in Section 2(a) of the Securities Act and are subject to reduced public company reporting requirements. You should read the Proxy Statement/Prospectus, this Supplement and any additional supplement or amendment carefully before investing in our securities.
Investing in our Class A ordinary shares and warrants involves a high degree of risk. See the section titled “Risk Factors” beginning on page 64 of the Proxy Statement/Prospectus and in any applicable supplement.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES AUTHORITY HAS APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED IN THE PROXY STATEMENT/PROSPECTUS OR THIS SUPPLEMENT, PASSED UPON THE MERITS OR FAIRNESS OF THE BUSINESS COMBINATION OR RELATED TRANSACTIONS OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THE PROXY STATEMENT/ PROSPECTUS OR THIS SUPPLEMENT. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE.
This Supplement is dated January 10, 2022.